ACH vs CTAS · rev $10.70B vs P/E 51, rev $10.34B
Accendra Health Inc (ACH) versus Cintas Corporation (CTAS) — a side-by-side from cached financials, not a winner call.
Accendra Health Inc (ACH) is a medical distribution company listed on NYSE.
Cintas Corporation (CTAS) is a specialty business services company listed on US.
Latest reported ACH revenue for 2024-12-31 was $10.70B. Net income was -$362.7M. Revenue was up 3.6% from 2023-12-31 to 2024-12-31. ACH currently screens at market cap $237.8M.
Latest reported CTAS revenue for 2025-05-31 was $10.34B. Net income was $1.81B. Revenue was up 7.7% from 2024-05-31 to 2025-05-31. CTAS currently screens at market cap $89.01B and trailing P/E 51.3.
ACH currently screens at market cap $237.8M. CTAS currently screens at market cap $89.01B and trailing P/E 51.3.
Not investment advice. Open the ACH and CTAS stock pages for the full models.
Not investment advice.